BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12716449)

  • 1. Collagen-induced arthritis is exacerbated in IL-10-deficient mice.
    Finnegan A; Kaplan CD; Cao Y; Eibel H; Glant TT; Zhang J
    Arthritis Res Ther; 2003; 5(1):R18-24. PubMed ID: 12716449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
    Stasiuk LM; Abehsira-Amar O; Fournier C
    Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the adjuvant effect of IL-12 and efficacy of IL-12 inhibitors in type II collagen-induced arthritis.
    Germann T; Hess H; Szeliga J; Rüde E
    Ann N Y Acad Sci; 1996 Oct; 795():227-40. PubMed ID: 8958934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
    Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
    Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis.
    Butler DM; Malfait AM; Maini RN; Brennan FM; Feldmann M
    Eur J Immunol; 1999 Jul; 29(7):2205-12. PubMed ID: 10427983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 promotes cellular but not humoral type II collagen-specific Th 1-type responses in C57BL/6 and B10.Q mice and fails to induce arthritis.
    Szeliga J; Hess H; Rüde E; Schmitt E; Germann T
    Int Immunol; 1996 Aug; 8(8):1221-7. PubMed ID: 8918691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice.
    Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Billiau A
    Eur J Immunol; 1998 Jul; 28(7):2143-51. PubMed ID: 9692883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice.
    Germann T; Szeliga J; Hess H; Störkel S; Podlaski FJ; Gately MK; Schmitt E; Rüde E
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4823-7. PubMed ID: 7761407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies.
    Johansson AC ; Hansson AS; Nandakumar KS; Bäcklund J; Holmdahl R
    J Immunol; 2001 Sep; 167(6):3505-12. PubMed ID: 11544344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted expression of anti-type II collagen antibody isotypes in mice suppressed for collagen-induced arthritis.
    Kresina TF; Finegan CK
    Ann Rheum Dis; 1986 Jan; 45(1):60-6. PubMed ID: 3954459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of proteoglycan-induced arthritis is independent of IL-17.
    Doodes PD; Cao Y; Hamel KM; Wang Y; Farkas B; Iwakura Y; Finnegan A
    J Immunol; 2008 Jul; 181(1):329-37. PubMed ID: 18566398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
    Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
    Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain.
    Guedez YB; Whittington KB; Clayton JL; Joosten LA; van de Loo FA; van den Berg WB; Rosloniec EF
    Arthritis Rheum; 2001 Oct; 44(10):2413-24. PubMed ID: 11665984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase.
    Ross AD; Banda NK; Muggli M; Arend WP
    Arthritis Rheum; 2004 Nov; 50(11):3702-11. PubMed ID: 15529385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated experimental arthritis in IL-33 deficient mice.
    Talabot-Ayer D; Martin P; Seemayer CA; Vigne S; Lamacchia C; Finckh A; Saiji E; Gabay C; Palmer G
    Cytokine; 2014 Sep; 69(1):68-74. PubMed ID: 25022964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced incidence and severity of collagen-induced arthritis in mice lacking IL-18.
    Wei XQ; Leung BP; Arthur HM; McInnes IB; Liew FY
    J Immunol; 2001 Jan; 166(1):517-21. PubMed ID: 11123331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
    Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
    Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance.
    Derry CJ; Harper N; Davies DH; Murphy JJ; Staines NA
    Arthritis Rheum; 2001 Aug; 44(8):1917-27. PubMed ID: 11508445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.